Next Article in Journal
Photodegradation Study of Sertindole by UHPLC-ESI-Q-TOF and Influence of Some Metal Oxide Excipients on the Degradation Process
Next Article in Special Issue
Penetration Enhancers in Ocular Drug Delivery
Previous Article in Journal
Potential Albumin-Based Antioxidant Nanoformulations for Ocular Protection against Oxidative Stress
Previous Article in Special Issue
Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Delivery of Nanoparticles across the Intestinal Epithelium via the Transferrin Transport Pathway

School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King’s College London, London SE1 9NH, UK
*
Author to whom correspondence should be addressed.
Pharmaceutics 2019, 11(7), 298; https://doi.org/10.3390/pharmaceutics11070298
Submission received: 17 May 2019 / Revised: 24 June 2019 / Accepted: 25 June 2019 / Published: 26 June 2019
(This article belongs to the Special Issue Transmucosal Absorption Enhancers in the Drug Delivery Field)

Abstract

The aim of this study was to probe whether the transferrin (Tf) transport pathway can be exploited for intestinal delivery of nanoparticles. Tf was adsorbed on 100 nm model polystyrene nanoparticles (NP), followed by size characterisation of these systems. Cell uptake of Tf and Tf-adsorbed NP was investigated in intestinal epithelial Caco-2 cells cultured on multi-well plates and as differentiated polarised monolayers. Tf-NP demonstrated a remarkably higher cell uptake compared to unmodified NP in both non-polarised (5-fold) and polarised cell monolayers (16-fold difference). Application of soluble Tf significantly attenuated the uptake of Tf-NP. Notably, Tf-NP displayed remarkably higher rate (23-fold) of epithelial transport across Caco-2 monolayers compared to unmodified NP. This study therefore strongly suggests that the Tf transport pathway should be considered as a candidate biological transport route for orally-administered nanomedicines and drugs with poor oral bioavailability.
Keywords: Caco-2; intestinal absorption; nanomedicine; nanoparticle; oral delivery; transferrin Caco-2; intestinal absorption; nanomedicine; nanoparticle; oral delivery; transferrin

Share and Cite

MDPI and ACS Style

Yong, J.M.; Mantaj, J.; Cheng, Y.; Vllasaliu, D. Delivery of Nanoparticles across the Intestinal Epithelium via the Transferrin Transport Pathway. Pharmaceutics 2019, 11, 298. https://doi.org/10.3390/pharmaceutics11070298

AMA Style

Yong JM, Mantaj J, Cheng Y, Vllasaliu D. Delivery of Nanoparticles across the Intestinal Epithelium via the Transferrin Transport Pathway. Pharmaceutics. 2019; 11(7):298. https://doi.org/10.3390/pharmaceutics11070298

Chicago/Turabian Style

Yong, Jing M., Julia Mantaj, Yiyi Cheng, and Driton Vllasaliu. 2019. "Delivery of Nanoparticles across the Intestinal Epithelium via the Transferrin Transport Pathway" Pharmaceutics 11, no. 7: 298. https://doi.org/10.3390/pharmaceutics11070298

APA Style

Yong, J. M., Mantaj, J., Cheng, Y., & Vllasaliu, D. (2019). Delivery of Nanoparticles across the Intestinal Epithelium via the Transferrin Transport Pathway. Pharmaceutics, 11(7), 298. https://doi.org/10.3390/pharmaceutics11070298

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop